Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
983 hedge funds and large institutions have $56.6B invested in Celgene Corp in 2013 Q4 according to their latest regulatory filings, with 123 funds opening new positions, 328 increasing their positions, 429 reducing their positions, and 43 closing their positions.
186% more first-time investments, than exits
New positions opened: 123 | Existing positions closed: 43
9% more capital invested
Capital invested by funds: $51.9B → $56.6B (+$4.75B)
8% more funds holding
Funds holding: 909 → 983 (+74)
10% less funds holding in top 10
Funds holding in top 10: 97 → 87 (-10)
18% less call options, than puts
Call options by funds: $949M | Put options by funds: $1.16B
24% less repeat investments, than reductions
Existing positions increased: 328 | Existing positions reduced: 429
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$245M |
| 2 |
Jennison Associates
New York
|
+$232M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$183M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$160M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$130M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$264M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$163M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$154M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$138M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$119M |
CELG Hedge Fund Activity: Q4 2013 in Review
983 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q4 2013, worth a combined $56.6B — up 9.2% from $51.9B a quarter earlier.
Buyers outnumbered sellers: 123 funds opened new CELG positions and 43 closed out — a net gain of 80 holders — while 328 added to existing stakes and 429 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $245M. The largest seller was Fidelity Investments, cutting an estimated $264M.
- 983 institutional investors held Celgene Corp (CELG) as of Q4 2013, up from 909 in Q3 2013.
- Funds reported $56.6B of Celgene Corp stock for Q4 2013, up 9.2% quarter-over-quarter.
- 123 funds opened new Celgene Corp positions in Q4 2013 and 43 closed out, a net change of +80 holders.
- The largest Celgene Corp buyer in Q4 2013 was JP Morgan Chase, an estimated $245M added.
- The largest Celgene Corp seller in Q4 2013 was Fidelity Investments, an estimated $264M sold.
Based on aggregated 13F filings for Q4 2013.